First Commonwealth Financial Corporation (FCF) Q1 2026 Earnings Call Transcript
First Commonwealth Financial Corporation (FCF) Q1 2026 Earnings Call Transcript
seekingalpha.com
AZN(AZN)
AZN
Signal
Bearish Setup1↑1↓
PRICE
Prev Close
186.73
Open
183.93
Day Range181.73 – 187.00
181.73
187.00
52W Range132.32 – 212.71
132.32
212.71
66% of range
VOLUME & SIZE
Avg Volume
2.1M
FUNDAMENTALS
P/E Ratio
28.4x
EPS (TTM)
—
Div Yield
0.02%
Beta
0.53
Low vol
Performance
1D
-0.96%5D↓
-4.87%1M
-1.44%3M
-1.11%6M
+12.16%YTD
+5.82%1Y↑
+33.84%Best: 1Y (+33.84%)Worst: 5D (-4.87%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +9% YoYValuation
EXPENSIVE
P/E 28x vs ~20x sectorHealth
MODERATE
FCF $6.61/shLean Bullish
Key MetricsTTM
Market Cap$282.48B
Revenue TTM$58.74B
Net Income TTM$10.22B
Free Cash Flow$10.57B
Gross Margin—
Net Margin—
Operating Margin—
Return on Equity23.0%
Return on Assets—
Debt / Equity0.61
Current Ratio0.94
EPS TTM$6.69
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
1 strong1 watch1 concern
47/100Leverage
0.61Strong
ROIC
13.1%Watch
Cash
$5.7BConcern
ANALYST COVERAGE39 analysts
HOLD
59/100 conviction▲ +13.9%upside to target
L $206.00
Med $211.00consensus
H $216.00Stock Health
Composite Score
1 of 3 signals bullish
6/10
Technicals
●
✗RSI RangeRSI 45 — Bearish momentum
Volume
●
✓Volume FlowAccumulation — institutional buying
Fundamentals
●
~Analyst ConsensusHold
2 signals unavailable — limited data for this stock
Upcoming Events
EEarnings ReportApr 30, 2026
Tomorrow
DEx-Dividend DateJul 28, 2026
In 90 days
PDividend PaymentAug 21, 2026
In 114 days
FinancialsFull statements →
Technicals
Technical SignalsMIXED
Technicals →4 Buy2 Sell1 Neutral7 signals
SellNeutralBuy
| Indicator | Value | Signal | Strength |
|---|---|---|---|
| RSI (14) | 45.1 | —NEUTRAL | 10% |
| SMA 50↓ RES | $193.1 | ▼BEARISH | 40% |
| SMA 200↑ SUPP | $144.4 | ▲BULLISH | 100% |
| EMA 50 | $184.5 | ▲BULLISH | 51% |
| EMA 200 | $154.2 | ▲BULLISH | 100% |
| MA Trend | 50D > 200D | ▲GOLDEN X | 100% |
| MACD | -2.23 | ▼BEARISH | 39% |
Key Levels
Resistance
SMA 50$193.14.1%
Support
SMA 200$144.428.3%
Market Position
Price Levels
52W High
$212.7+14.9%
Current
$185.2
EMA 50
$184.5-0.4%
EMA 200
$154.2-16.7%
52W Low
$132.3-28.6%
52-Week RangeMid-range
$132.366th %ile$212.7
RSI (14)45.1
Momentum neutral-to-bearish
Squeeze SetupVolume-based
Moderate Squeeze SetupAccumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.
20-Day Money Flow
Acc days:1
Dist days:3
Edge:+2 dist
Volume Context
Avg Vol (50D)2.2M
Recent Vol (5D)
1.7M-22%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 17 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $58.6B $57.4B–$59.4B | — | $9.16 | — | ±3% | High17 |
FY2026(current) | $63.3B $62.2B–$64.3B | ▲ +7.9% | $10.28 | ▲ +12.2% | ±2% | High17 |
FY2027 | $67.7B $64.6B–$69.3B | ▲ +7.0% | $11.62 | ▲ +13.1% | ±4% | High17 |
Range confidence:Tight (high)ModerateWide (low)
Analyst Activity
All ratings →No recent activity
Deutsche BankSell → Hold
Sep 13
DOWNGRADE
Deutsche BankHold → Sell
Sep 12
DOWNGRADE
NordeaSell
Sep 11
DOWNGRADE
Deutsche BankHold
Apr 16
UPGRADE
JefferiesBuy
Sep 25
UPGRADE
Financials
Dividends1.75% yield
+144.2% avg annual growthAnnual Yield1.75%
Semi-Annual Div.$2.1700
Est. Annual / Share$4.34
FrequencySemi-Annual
Q3'22
Q1'23
Q3'23
Q1'24
Q3'24
Q1'25
Q3'25
Q1'26
Dividend per payment — last 8 periods
INSTITUTIONAL OWNERSHIP
1
Pictet Asset Management Holding SA
3.5M▲2
ABN AMRO Bank N.V.
2.4M▲3
Lansforsakringar Fondforvaltning AB (publ)
2.4M▲4
Border to Coast Pensions Partnership Ltd
2.0M▲5
Ninety One UK Ltd
2.0M▲6
LGT Group Foundation
1.9M▲7
Artemis Investment Management LLP
1.4M▲8
Assenagon Asset Management S.A.
929K▲News & Activity
AZN News
20 articles · 4h ago
CSRE: The Secret Sauce Of This Outperforming Active REIT ETF
seekingalpha.com
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
prnewswire.com
GOSS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026
newsfilecorp.com
A Wild Short Squeeze on Avis's Stock Takes Another Surprising Turn
wsj.com
O-I Glass, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
globenewswire.com
DEFSEC Ships New BLISS ("Battlespace Laser Identification Sensor System") To U.S. Army Yuma Test Center
prnewswire.com
Board Declares Quarterly Dividend
prnewswire.com
Meta Q1: Thanks For The Dip, I'm Buying More
seekingalpha.com
United States Lime & Minerals Reports First Quarter 2026 Results and Declares Regular Quarterly Cash Dividend
globenewswire.com
Elon Musk blasts OpenAI 'bait-and-switch' during heated Day 2 testimony
businessinsider.com
Renasant Corporation (RNST) Q1 2026 Earnings Call Transcript
seekingalpha.com
BSX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026
newsfilecorp.com
ServiceNow: The AI Control Tower The Market Is Ignoring
seekingalpha.com
Pulse Seismic Inc. Announces Voting Results at Shareholders' Annual Meeting
globenewswire.com
AQST DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - AQST
newsfilecorp.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
newsfilecorp.com
TransAlta Declares Dividends
globenewswire.com
Early Warning Report and News Release Regarding Securities of Dixie Gold Inc.
newsfilecorp.com
Wallick Investments Celebrates Continued 5-Star Overall Morningstar Rating™ for Inspire Fidelis Multi-Factor ETF (FDLS)
businesswire.com
About
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Pascal Soriot
Country
United Kingdom
Website
Susan Mary GalbraithExecutive Vice President of Oncology R&D
Iskra ReicExecutive Vice President of International
Ruth MarchSenior Vice President of Precision Medicine - R&D Oncology
Peers— —(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
AZN◀ | $185.20 | -0.96% | $289.4B | — | — | — | 1500 |
| $393.83 | -3.12% | $2.0T | 29.8 | +3296.8% | 4510.0% | 1500 | |
| $89.28 | +0.00% | $311.7B | — | — | — | 1500 | |
| $130.45 | -1.28% | $303.7B | — | +586.3% | — | 1500 | |
| $142.94 | +0.00% | $280.9B | — | +597.3% | — | 1500 | |
| $191.26 | +0.42% | $251.5B | 11.0 | +652.3% | 992.0% | 1500 | |
| $175.22 | +0.00% | $248.3B | — | +213.3% | — | 1500 | |
| Sector avg | — | -0.70% | — | 20.4 | +1069.2% | 2751.0% | 1500 |